1. Home
  2. RGEN vs CART Comparison

RGEN vs CART Comparison

Compare RGEN & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CART
  • Stock Information
  • Founded
  • RGEN 1981
  • CART 2012
  • Country
  • RGEN United States
  • CART United States
  • Employees
  • RGEN N/A
  • CART N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CART
  • Sector
  • RGEN Health Care
  • CART
  • Exchange
  • RGEN Nasdaq
  • CART Nasdaq
  • Market Cap
  • RGEN 7.6B
  • CART 11.2B
  • IPO Year
  • RGEN N/A
  • CART 2023
  • Fundamental
  • Price
  • RGEN $156.55
  • CART $46.45
  • Analyst Decision
  • RGEN Buy
  • CART Buy
  • Analyst Count
  • RGEN 12
  • CART 25
  • Target Price
  • RGEN $187.44
  • CART $48.90
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • CART 4.4M
  • Earning Date
  • RGEN 02-19-2025
  • CART 02-11-2025
  • Dividend Yield
  • RGEN N/A
  • CART N/A
  • EPS Growth
  • RGEN N/A
  • CART N/A
  • EPS
  • RGEN N/A
  • CART 1.53
  • Revenue
  • RGEN $633,513,000.00
  • CART $3,298,000,000.00
  • Revenue This Year
  • RGEN $2.28
  • CART $13.51
  • Revenue Next Year
  • RGEN $9.88
  • CART $9.01
  • P/E Ratio
  • RGEN N/A
  • CART $30.28
  • Revenue Growth
  • RGEN N/A
  • CART 10.08
  • 52 Week Low
  • RGEN $113.50
  • CART $22.70
  • 52 Week High
  • RGEN $211.13
  • CART $50.01
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • CART 62.15
  • Support Level
  • RGEN $149.15
  • CART $43.07
  • Resistance Level
  • RGEN $160.64
  • CART $45.57
  • Average True Range (ATR)
  • RGEN 5.96
  • CART 1.53
  • MACD
  • RGEN 0.91
  • CART 0.36
  • Stochastic Oscillator
  • RGEN 79.57
  • CART 93.60

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CART Maplebear Inc.

Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.

Share on Social Networks: